Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in children worldwide and is a significant cause of hospital admissions in young children in England. No RSV vaccine has been licensed but a number are under development. In this work, we present two structurally d...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Timothy Kinyanjui, Wirichada Pan-Ngum, Sompob Saralamba, Sylvia Taylor, Lisa White, D. James Nokes
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Elsevier 2020-04-01
Seri Bilgileri:Vaccine: X
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2590136220300024